Year None2021202020192018201720162015201420132012 10.31.2018 Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) 10.31.2018 Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 10.23.2018 Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 10.04.2018 Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration 10.03.2018 Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference 08.22.2018 Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences 08.01.2018 Ophthotech Reports Second Quarter 2018 Financial and Operating Results 07.25.2018 Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 06.07.2018 Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania 05.09.2018 Ophthotech Reports First Quarter 2018 Financial and Operating Results Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last »